PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Dec-2025 Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy Businesswire
09-Dec-2025 PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer Businesswire
09-Dec-2025 RunSafe Security Releases 2025 AI in Embedded Systems Report Offering New Insight Into AI Adoption and Security Gaps Businesswire
09-Dec-2025 SciencePower Collaborates to Advance Research on Postbiotics in Breast Cancer Biology Businesswire
09-Dec-2025 Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada Businesswire
09-Dec-2025 SAGA Diagnostics’ Pathlight™ MRD Further Demonstrates Clinical Validity In TNBC Trials Presented at SABCS Businesswire
09-Dec-2025 Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET Businesswire
09-Dec-2025 Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma Businesswire
09-Dec-2025 World’s First Patients Successfully Treated With Novel Scarcell Therapeutics Therapy Using Gum Cells Designed to Relieve Knee Osteoarthritis Businesswire
09-Dec-2025 AFYREN and ESSE Skincare Begin Partnership to Offer 100% Natural Cosmetic Solutions With Enhanced Skincare Performance Businesswire
09-Dec-2025 SonoThera Presents New Data at ASH 2025 Demonstrating Durable Factor VIII Expression Using Ultrasound Mediated Gene Delivery in Treating Hemophilia A Businesswire
09-Dec-2025 Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT) Businesswire
09-Dec-2025 Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas Businesswire
09-Dec-2025 Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025 Businesswire
09-Dec-2025 Qihan Biotech Presents New Clinical Data on Allogeneic CAR-T Cell Therapies and Preclinical Data on In Vivo CAR-T at the American Society of Hematology (ASH) Annual Meeting Businesswire
09-Dec-2025 AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Businesswire
08-Dec-2025 Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting Businesswire
08-Dec-2025 Cellarity Presents on Cell State-Correcting Pipeline Programs for Sickle Cell Disease and Myelofibrosis at 2025 American Society of Hematology Annual Meeting Businesswire
08-Dec-2025 Number of Shares and Voting Rights of ADOCIA as of December 8th, 2025 Businesswire
08-Dec-2025 Flashpoint Therapeutics’ Scientific Founder Chad A. Mirkin Awarded the Prestigious Harvey Prize Businesswire